Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1–42 levels

Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40).

Jon R. Backstrom, Giselle P. Lim, Michael J. Cullen et al. · PubMed · 1996 · 349 citations · Full text

Life Sciences, Neurobiology, Neuroscience +16

Matrix Metalloproteinase-9 (MMP-9) Is Synthesized in Neurons of the Human Hippocampus and Is Capable of Degrading the Amyloid-β Peptide (1–40)

Jon R. Backstrom, Giselle P. Lim, Michael J. Cullen et al. · Journal of Neuroscience · 1996 · 315 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease

Pascual Sánchez‐Juan, A. Green, Anna Ladogana et al. · Neurology · 2006 · 288 citations

Medicine, Genetics, Neurology +17

Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Anthony R. White, Tai Du, Katrina Laughton et al. · Journal of Biological Chemistry · 2006 · 283 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae

David Leppert, Stephen L. Leib, Caroline Grygar et al. · Clinical Infectious Diseases · 2000 · 263 citations · Full text

Medicine, Infectious Diseases, Neurology +12